ProPhase Labs, Inc.

PRPHNASDAQHealthcare● Active

$0.10

$-0.01(-9.09%)

Market Cap$473701

P/E Ratio—

52W High$6.7

52W Low$0.07

Avg Volume158K

Open$0.09

Beta0.07

Net Income Financials Revenue

ProPhase Labs, Inc. (PRPH) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PRPH · net income · updated Jun 9, 2026

Core profitability metrics

PRPH · net income · margin · TTM · CAGR

Net income was −$14.7M for FY2025 (fiscal year ending 2025-12-31), up 72.4% year-over-year. Net profit margin was -339.3%. Based on available data, ProPhase Labs, Inc. has been profitable since at least 2013.

FY2025 Net Income−$14.7M▲ +72.4% YoY

Trailing 12M (TTM)−$14.7Mtrailing 4 quarters sum

Net Profit Margin-339.3%−$14.7M ÷ $4.3M

YoY Change+72.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · PRPH net income history · PRPH profit margin

Annual net income data

PRPH · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$14.7M▲ +72.4%-339.3%$4.3M

FY2024Loss−$53.4M▼ 218.0%-788.2%$6.8M

FY2023Loss−$16.8M▼ 190.9%-37.8%$44.4M

FY2022$18.5M▲ +194.3%15.1%$122.6M

FY2021$6.3M▲ +395.2%7.9%$79.0M

Net income vs peers (Healthcare)

PRPH vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

ProPhase Labs, Inc.YOU

PRPH

−$14.7M+72.4%-339.3%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

ProPhase Labs, Inc. (PRPH) reported net income of −$14.7M for FY2025 (fiscal year ending 2025-12-31), up 72.4% year-over-year. The net profit margin was -339.3% — meaning the company kept $-3.39 of every dollar of revenue as profit.

Based on available data, ProPhase Labs, Inc. has been profitable since at least 2013. Net income reached a peak of $41.8M in FY2017. Data available for 15 fiscal years.

ProPhase Labs, Inc.'s net profit margin was -339.3% for FY2025, based on the latest annual results.

Investors sometimes search for "ProPhase Labs, Inc. net worth" — the company's market capitalization is a separate figure from PRPH net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

PRPH net income · 4 questions

ProPhase Labs, Inc. is not currently profitable on an annual basis. The company reported a net loss of $14.7M for FY2025.

is PRPH profitabledoes PRPH make a profitPRPH profitabilityPRPH profitable company

▸ Source: FMP /income-statement · GAAP · ProPhase Labs, Inc. · ProPhase Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026